Menu
Medical Condition
Bariatric / Weight Loss Surgery
Bariatric / Weight Loss Surgery ICD-10: T18.2

Bezoar Formation (Gastric)

Accumulation of indigestible food material in the gastric pouch due to altered anatomy and reduced motility.

Medical Disclaimer
This condition guide is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any symptoms or medical conditions.

Clinical Assessment & Protocol

Typical Presentation (HPI)

Early satiety, epigastric fullness, and progressive vomiting after meals.

General Examination

Unremarkable or not routinely indicated.

Treatment Protocol

Endoscopic fragmentation or mechanical removal.

Patient Education

Thorough chewing of food and avoidance of high-fiber, fibrous vegetables.

Systemic & Specialized Examinations

Cardiovascular

EN: S1, S2 present. No murmurs. AR: صوتا القلب الأول والثاني طبيعيان. لا توجد نفخات.

Respiratory

EN: Lungs clear to auscultation. AR: الرئتان صافيتان عند التسمع.

Gastrointestinal

EN: Palpable epigastric mass in thin patients; visible obstruction on endoscopy. AR: كتلة شرسوفية ملموسة في المرضى النحفاء؛ انسداد مرئي بالمنظار.

Neurological

EN: Alert, oriented x3. No focal deficits. AR: المريض واعي ومدرك. لا يوجد عجز عصبي بؤري.

Dermatological

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Psychiatric

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

OB/GYN

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Ophthalmic

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Dental

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Comprehensive Clinical Guide: Gastric Bezoar Formation

1. Introduction and Overview

A gastric bezoar is a solid, indigestible mass of accumulated foreign material that becomes trapped within the gastrointestinal system, most commonly the stomach. Derived from the Persian word "pād-zahr" (antidote), bezoars were historically shrouded in medical mythology. In modern clinical practice, they represent a significant diagnostic challenge, often mimicking malignancy, peptic ulcer disease, or mechanical obstruction.

While rare in the general population, bezoars are critical to identify in patients with altered gastric anatomy (e.g., post-vagotomy or gastric bypass), delayed gastric emptying (gastroparesis), or psychiatric comorbidities (e.g., trichotillomania). If left untreated, they can lead to severe complications, including gastric outlet obstruction, mucosal ulceration, hemorrhage, and perforation.


2. Etiology and Classification

Bezoars are classified primarily by their composition. Understanding the material is paramount, as the chemical nature dictates the therapeutic approach (e.g., enzymatic dissolution vs. endoscopic fragmentation vs. surgical intervention).

Table 1: Classification of Gastric Bezoars

Type Composition Common Patient Profile
Phytobezoar Vegetable/fruit fibers (cellulose, lignin) Elderly, post-gastric surgery, poor dentition.
Trichobezoar Human hair Psychiatric history, trichotillomania, trichophagia.
Pharmacobezoar Undissolved medication (e.g., sucralfate, antacids) Patients on polypharmacy with gastroparesis.
Lactobezoar Milk protein/curds Premature infants fed high-calorie formula.
Diospyrobezoar Persimmon fibers High tannin consumption (reacts with gastric acid).

Pathophysiological Mechanisms

The formation of a bezoar generally follows a tripartite mechanism:
1. Nidus Formation: The accumulation of indigestible material begins, often facilitated by impaired gastric motility or anatomy.
2. Aggregation: Material binds together. In phytobezoars, tannins and cellulose form a dense matrix. In trichobezoars, the smooth surface of hair prevents passage through the pylorus, allowing it to "felt" together via gastric peristalsis.
3. Maturation: Over weeks or months, the mass grows. As it enlarges, it may take the shape of the stomach, a condition known as Rapunzel Syndrome when the tail of the trichobezoar extends into the small intestine.


3. Clinical Staging and Presentation

There is no universally accepted "staging" system for bezoars in the same way there is for oncology; however, clinicians categorize them by Size and Complication Status.

  • Stage I (Simple): Asymptomatic or mild epigastric discomfort.
  • Stage II (Symptomatic): Early satiety, nausea, vomiting, epigastric pain.
  • Stage III (Complicated): Evidence of gastric outlet obstruction, hematemesis (due to ulceration), or acute abdomen (due to perforation).

Standard Clinical Presentation

Symptoms are notoriously non-specific, leading to diagnostic delays. The "classic" presentation includes:
* Postprandial Epigastric Pain: Often described as a "fullness" that does not resolve.
* Early Satiety: The bezoar occupies physical volume within the lumen.
* Halitosis: Bacterial fermentation of the trapped material produces foul-smelling gases.
* Palpable Mass: In thin patients, a mobile, firm epigastric mass may be palpable.


4. Diagnostic Workup and Differential Diagnosis

Key Diagnostic Tests

  1. Upper Endoscopy (EGD): The gold standard. It allows for direct visualization, biopsy (to rule out malignancy), and potential immediate therapeutic intervention.
  2. Computed Tomography (CT) Scan: The modality of choice for suspected obstruction. It typically reveals a well-circumscribed, mottled mass within the gastric lumen with a gas-trapping appearance.
  3. Upper GI Series (Barium Swallow): Can demonstrate a filling defect, though it is less commonly used now due to the prevalence of CT and EGD.

Differential Diagnosis

  • Gastric Adenocarcinoma: Can mimic the appearance of a bezoar. Always biopsy the mucosa beneath a bezoar.
  • Gastric Polyp: Usually fixed to the wall, unlike the mobile bezoar.
  • Foreign Body ingestion: Differentiated by history and radiodensity.
  • Peptic Ulcer Disease: Often co-occurs; the bezoar may be a secondary complication of the ulceration.

5. Risks, Contraindications, and Management

Clinical Management Strategy

Management is dictated by the composition and size of the mass.
* Chemical Dissolution: Specifically for phytobezoars. Agents include cellulase, papain, or Coca-Cola (the acidity and carbonation are thought to degrade the fibers). Contraindication: Do not attempt if the patient has an existing gastric outlet obstruction, as the breakdown products may pass into the small bowel and cause an ileus.
* Endoscopic Fragmentation: Use of lithotripsy, snares, or biopsy forceps to break the mass into smaller pieces for retrieval.
* Surgical Intervention: Reserved for massive bezoars (e.g., Rapunzel Syndrome) or cases where endoscopic attempts have failed or perforation is suspected.

Risks and Complications

  • Gastric Ulceration: Direct pressure necrosis leads to ischemic ulcers.
  • Perforation: Usually occurs at the site of the pylorus or greater curvature.
  • Small Bowel Obstruction (SBO): Migration of fragments post-fragmentation.
  • Aspiration: During endoscopic retrieval, the risk of vomiting and subsequent aspiration is significant.

6. Frequently Asked Questions (FAQ)

1. Can a bezoar be fatal?
Yes. If a bezoar causes massive gastric perforation or complete bowel obstruction, it can lead to sepsis and death if not managed surgically.

2. Why is Coca-Cola used to treat phytobezoars?
The combination of low pH (acidic) and carbonation helps dissolve cellulose fibers. However, it is only effective for small, soft phytobezoars.

3. What is Rapunzel Syndrome?
A rare, extreme form of trichobezoar where the mass starts in the stomach but extends its "tail" through the pylorus into the jejunum or ileum.

4. How do I distinguish a bezoar from a tumor on a CT scan?
Bezoars typically have a "mottled" gas-bubble appearance within the mass, whereas tumors appear as solid, enhancing masses or wall thickenings.

5. Are all bezoars the same color?
No. Phytobezoars are often green/brown (vegetable matter), while trichobezoars appear black or dark brown due to the denaturation of hair proteins.

6. Can a bezoar be passed naturally?
Very rarely. If a bezoar is small enough to pass the pylorus, it usually causes a small bowel obstruction downstream, which is a surgical emergency.

7. Why do patients with gastric bypass get bezoars?
Altered anatomy and reduced gastric acid production change the "grinding" capability of the stomach, allowing fibers to accumulate.

8. Is psychiatric follow-up necessary?
Essential for trichobezoar patients. Without addressing the underlying trichophagia, the recurrence rate is extremely high.

9. What is the most common age group for trichobezoars?
Adolescent females, though it can occur in any age group with psychiatric comorbidities.

10. What is the long-term prognosis?
Excellent if the underlying cause (e.g., poor motility, psychiatric issues, or dietary habits) is addressed. Recurrence is the primary long-term risk.


7. Clinical Summary and Best Practices

The management of gastric bezoars requires a multidisciplinary approach. Primary care providers should maintain a high index of suspicion in patients with chronic dyspepsia and a history of psychiatric illness or gastric surgery.

Proactive Clinical Tips:
* Always exclude malignancy: Never assume a mass is "just a bezoar" without visual confirmation.
* Monitor for SBO: Post-endoscopic fragmentation, monitor the patient for signs of small bowel obstruction as fragments pass.
* Psychiatric Referral: For trichobezoar cases, the surgeon or gastroenterologist must partner with a psychiatrist to prevent re-formation.
* Dietary Counseling: For phytobezoars, counsel patients on the importance of chewing food thoroughly, especially those with dental issues or previous gastric bypass.

This condition serves as a reminder that the gastrointestinal tract is a mechanical system; when motility or anatomy is compromised, the accumulation of "environmental" debris is a predictable, albeit complex, clinical reality.


Disclaimer: This guide is intended for educational purposes for healthcare professionals and medical students. It does not replace institutional protocols or individual clinical judgment. Always consult current clinical guidelines (e.g., ACG or ASGE) for specific patient management.

Treatment & Management Options

Recommended Medications

Share this guide: